Navigation Links
Flightless mosquitoes developed to help control dengue fever
Date:2/22/2010

Irvine, Calif. A new strain of mosquitoes in which females cannot fly may help curb the transmission of dengue fever, according to UC Irvine and British scientists.

Dengue fever causes severe flulike symptoms and is among the world's most pressing public health issues. There are 50 million to 100 million cases per year, and nearly 40 percent of the global population is at risk. The dengue virus is spread through the bite of infected female Aedes aegypti mosquitoes, and there is no vaccine or treatment.

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing or even eliminating dengue transmission. Males of the strain can fly but do not bite or convey disease.

When genetically altered male mosquitoes mate with wild females and pass on their genes, females of the next generation are unable to fly. Scientists estimate that if released, the new breed could sustainably suppress the native mosquito population in six to nine months. The approach offers a safe, efficient alternative to harmful insecticides.

Study results appear in the early online edition of the Proceedings of the National Academy of Sciences for the week of Feb. 22. The research is receiving funding support from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative, which was launched to support breakthrough advances for health challenges in the developing world.

"Current dengue control methods are not sufficiently effective, and new ones are urgently needed," said Anthony James, Distinguished Professor of microbiology & molecular genetics and molecular biology & biochemistry at UCI and an internationally recognized vector biologist. "Controlling the mosquito that transmits this virus could significantly reduce human morbidity and mortality."

Using concepts developed by Oxitec's Luke Alphey, the study's senior author, researchers made a genetic alteration in the mosquitoes that disrupts wing muscle development in female offspring, rendering them incapable of flight. Males' ability to fly is unaffected, and they show no ill effects from carrying the gene.

"The technology is completely species-specific, as the released males will mate only with females of the same species," Alphey said. "It's far more targeted and environmentally friendly than approaches dependent upon the use of chemical spray insecticides, which leave toxic residue."

"Another attractive feature of this method is that it's egalitarian: All people in the treated areas are equally protected, regardless of their wealth, power or education," he added.

James and Alphey have pioneered the creation of genetically altered mosquitoes to limit transmission of vector-borne illnesses. While their current work is focused on the dengue fever vector, they noted that this approach could be adapted to other mosquito species that spread such diseases as malaria and West Nile fever.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. Smaller mosquitoes are more likey to be infected with viruses causing human diseases
2. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
3. Fleas and Ticks and Mosquitoes! Oh My!
4. Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus)
5. Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes
6. Microbiotic technology developed for microinjection of zebrafish embryos
7. Lab-on-chip testing for bird flu developed by Singapore scientists
8. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
9. New Denver Area Program Developed For Teens in Crisis
10. Genomic technologies to identify toxic chemicals should be developed
11. New system for classifying infant lung disease developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: